Sales of dementia drugs steadily growing in Russia

Sales of drugs against dementia are steadily growing in Russia these days, as the number of patients who suffer from the disease is also growing, The Pharma Letter’s local correspondent reports.

According to official statistics, sales of anti-dementia drugs in the local market have grown by a third in the last three years – both in value and volume terms. In Russia, approximately 2 million people already have Alzheimer's disease and other dementia-related conditions. Due to increased life expectancy and associated brain damage, this number will only increase.

According to the analytical company RNC Pharma, sales of drugs against dementia have been growing in Russia for the third year in a row.  In the first seven months of 2025 they exceeded 5 billion roubles (~$63 million), which is 16% more than in the same period last year (consumption in packages increased by 14% this year). Also in 2024, sales grew by up to 18%, compared to 2023.